{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T11:03:05Z","timestamp":1784890985824,"version":"3.55.0"},"reference-count":60,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Background: Atopic dermatitis (AD) and asthma are common type 2 inflammatory diseases linked by the atopic march. In adults with AD, the prevalence of comorbid asthma and the strength of the AD\u2013asthma association remain uncertain, with marked heterogeneity across studies. Moreover, the role of modern systemic therapies in this comorbidity is increasingly debated. Objective: To estimate the global pooled prevalence of asthma in adults with AD, quantify the AD\u2013asthma association, and discuss the potential impact of targeted therapies (dupilumab, abrocitinib, omalizumab) on asthma comorbidity. Methods: Systematic review and random-effects meta-analysis (ID CRD420261304804) of observational studies from PubMed, EMBASE, and Cochrane Library (inception to 19 January 2026). Pooled prevalence and odds ratios (ORs) were calculated, with subgroup analyses by region, ethnicity, and disease definition. Results: Seventy-five studies were included. The global pooled prevalence of asthma in adults with AD was 25.9% (95% CI 22.1\u201330.0%; I2 = 99.9%). AD was significantly associated with asthma (OR 3.64, 95% CI 2.89\u20134.57; I2 = 98.6%). Prevalence varied from 9.3% in Asia to 63.2% in South America. Although dupilumab and other targeted agents are effective in both diseases, isolated reports of new-onset asthma after treatment were identified; these cases more likely reflect the natural progression of AD or unmasking of pre-existing asthma than a direct adverse drug reaction. Conclusions: Asthma is highly prevalent in adults with AD and is strongly associated with AD. Geographic and ethnic disparities call for stratified screening. Clinicians should be aware that new-onset respiratory symptoms during targeted therapy may represent AD-related comorbidity rather than drug-induced asthma.<\/jats:p>","DOI":"10.3390\/ph19081149","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T10:38:41Z","timestamp":1784889521000},"page":"1149","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Global Prevalence of Asthma in Adults with Atopic Dermatitis and the Atopic Dermatitis\u2013Asthma Association"],"prefix":"10.3390","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-3275-261X","authenticated-orcid":false,"given":"Haojie","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Peking University Third Hospital, Beijing 100191, China"},{"name":"Department of Pharmacy Administration and Clinical Pharmacy, Peking University, Beijing 100191, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3801-0881","authenticated-orcid":false,"given":"Yichen","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Peking University Third Hospital, Beijing 100191, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiachen","family":"Tu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Peking University Third Hospital, Beijing 100191, China"},{"name":"Research Group of Jian Gong on Pharmacoepidemiology and Clinical Drug Evaluation, School of Clinical Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9872-4212","authenticated-orcid":false,"given":"Mengmeng","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Peking University Third Hospital, Beijing 100191, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libo","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Peking University Third Hospital, Beijing 100191, China"},{"name":"Department of Pharmacy Administration and Clinical Pharmacy, Peking University, Beijing 100191, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1172\/JCI21060","article-title":"New insights into atopic dermatitis","volume":"113","author":"Leung","year":"2004","journal-title":"J. Clin. Investig."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.jaci.2025.01.013","article-title":"Update on atopic dermatitis","volume":"155","author":"Meledathu","year":"2025","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archderm.142.5.561","article-title":"Development of atopic dermatitis during the first 3 years of life: The Copenhagen prospective study on asthma in childhood cohort study in high-risk children","volume":"142","author":"Halkjaer","year":"2006","journal-title":"Arch. Dermatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/j.jaci.2022.03.008","article-title":"Atopic dermatitis and the atopic march: Considering racial and ethnic diversity in atopic disease progression","volume":"149","author":"Takeshita","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.jaci.2016.03.010","article-title":"Precision medicine in patients with allergic diseases: Airway diseases and atopic dermatitis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology","volume":"137","author":"Muraro","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1515\/jtim-2015-0026","article-title":"Asthma and chronic obstructive pulmonary disease overlap syndrome: An update","volume":"3","author":"Lu","year":"2015","journal-title":"J. Transl. Intern. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1038\/ng.3985","article-title":"Shared genetic origin of asthma, hay fever and eczema elucidates allergic disease biology","volume":"49","author":"Ferreira","year":"2017","journal-title":"Nat. Genet."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s12016-018-8711-2","article-title":"Contact Dermatitis in Atopic Dermatitis Children-Past, Present, and Future","volume":"56","author":"Borok","year":"2019","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1001\/jamadermatol.2018.4061","article-title":"Genetic, Clinical, and Environmental Factors Associated With Persistent Atopic Dermatitis in Childhood","volume":"155","author":"Thorsteinsdottir","year":"2019","journal-title":"JAMA Dermatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1016\/S0140-6736(17)31191-1","article-title":"Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): A 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial","volume":"389","author":"Blauvelt","year":"2017","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jaci.2018.08.022","article-title":"Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis","volume":"143","author":"Bissonnette","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1001\/jamadermatol.2019.2855","article-title":"Efficacy and Safety of Oral Janus Kinase 1 Inhibitor Abrocitinib for Patients with Atopic Dermatitis: A Phase 2 Randomized Clinical Trial","volume":"155","author":"Gooderham","year":"2019","journal-title":"JAMA Dermatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","article-title":"Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma","volume":"378","author":"Castro","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1056\/NEJMoa1804093","article-title":"Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma","volume":"378","author":"Rabe","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jaci.2023.01.020","article-title":"Comparative effectiveness of omalizumab, mepolizumab, and dupilumab in asthma: A target trial emulation","volume":"151","author":"Akenroye","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/all.14221","article-title":"Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines\u2014Recommendations on the use of biologicals in severe asthma","volume":"75","author":"Agache","year":"2020","journal-title":"Allergy"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1515\/jtim-2026-0001","article-title":"Effects of T2-high asthma heterogeneity and inhaled corticosteroid on airway and metabolic profiles: A multi-omic approach","volume":"14","author":"Duan","year":"2026","journal-title":"J. Transl. Intern. Med."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Russo, D., Di Filippo, P., Di Pillo, S., Chiarelli, F., and Attanasi, M. (2023). New Indications of Biological Drugs in Allergic and Immunological Disorders: Beyond Asthma, Urticaria, and Atopic Dermatitis. Biomedicines, 11.","DOI":"10.3390\/biomedicines11020236"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1515\/jtim-2023-0135","article-title":"Selective HDAC8 inhibition by PCI-34051 attenuates inflammation and airway remodeling in asthma via miR-381-3p-TGF\u03b23 axis","volume":"12","author":"Bai","year":"2024","journal-title":"J. Transl. Intern. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1001\/jamadermatol.2024.1283","article-title":"Parental E-Cigarette Use and Pediatric Atopic Dermatitis","volume":"160","author":"Youn","year":"2024","journal-title":"JAMA Dermatol."},{"key":"ref_21","unstructured":"Leyi, H., Yinli, Z., Hui, X., Yajia, L., Zhiru, Z., Ziyi, X., Yixuan, T., Kun, H., Sidan, W., and Minxue, S. (2026). Emerging Contaminants and Their Impacts on Atopic Dermatitis: Current Mechanisms and Future Perspectives. Innov. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1001\/jamadermatol.2024.3717","article-title":"Drug Survival of Dupilumab, Methotrexate, and Cyclosporine A in Children With Atopic Dermatitis","volume":"161","author":"Kamphuis","year":"2025","journal-title":"JAMA Dermatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jaad.2020.02.055","article-title":"Prevalence of asthma in patients with atopic dermatitis: A systematic review and meta-analysis","volume":"84","author":"Ravnborg","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1515\/mr-2024-0078","article-title":"Yoga and chronic diseases: An umbrella review of systematic reviews and meta-analyses","volume":"5","author":"Wang","year":"2025","journal-title":"Med. Rev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1126\/science.1221064","article-title":"New paradigms in type 2 immunity","volume":"337","author":"Pulendran","year":"2012","journal-title":"Science"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e2515094","DOI":"10.1001\/jamanetworkopen.2025.15094","article-title":"Phenotypes of Atopic Dermatitis and Development of Allergic Diseases","volume":"8","author":"Sitarik","year":"2025","journal-title":"JAMA Netw. Open"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1001\/jamadermatol.2021.2657","article-title":"Association of Atopic Dermatitis and Mental Health Outcomes Across Childhood: A Longitudinal Cohort Study","volume":"157","author":"Kern","year":"2021","journal-title":"JAMA Dermatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1111\/bjd.15489","article-title":"Burden of respiratory comorbidities in patients with atopic dermatitis and psoriasis","volume":"177","author":"Andersen","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e2544324","DOI":"10.1001\/jamanetworkopen.2025.44324","article-title":"Incidence and Remission of Atopic Dermatitis in a German Birth Cohort","volume":"8","author":"Hung","year":"2025","journal-title":"JAMA Netw. Open"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e2462176","DOI":"10.1001\/jamanetworkopen.2024.62176","article-title":"Race-Specific and Race-Neutral Equations for Lung Function and Asthma Diagnosis in Black Children","volume":"8","author":"Chang","year":"2025","journal-title":"JAMA Netw. Open"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1001\/jamadermatol.2025.2073","article-title":"Predictors of Flares and Disease Severity in Patients With Atopic Dermatitis Using Machine Learning","volume":"161","author":"Nielsen","year":"2025","journal-title":"JAMA Dermatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.jaci.2022.12.002","article-title":"Comorbidities of atopic dermatitis-what does the evidence say?","volume":"151","author":"Thyssen","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.jaci.2021.10.019","article-title":"Epidemiology and management of asthma and atopic dermatitis in Sub-Saharan Africa","volume":"148","author":"Skevaki","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1016\/j.jaip.2022.05.019","article-title":"Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis","volume":"10","author":"Wechsler","year":"2022","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1542\/peds.111.3.608","article-title":"Atopic dermatitis and asthma: Parallels in the evolution of treatment","volume":"111","author":"Eichenfield","year":"2003","journal-title":"Pediatrics"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Al-Jahdali, H., Wali, S., Albanna, A.S., Allehebi, R., Al-Matar, H., Fattouh, M., and Beekman, M. (2022). Prevalence of eosinophilic, atopic, and overlap phenotypes among patients with severe asthma in Saudi Arabia: A cross-sectional study. BMC Pulm. Med., 22.","DOI":"10.1186\/s12890-022-01856-9"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1365-2222.1995.tb01088.x","article-title":"Interleukin-4 and interferon-gamma production in atopic and non-atopic children with asthma","volume":"25","author":"Tang","year":"1995","journal-title":"Clin. Exp. Allergy J. Br. Soc. Allergy Clin. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jaip.2023.11.009","article-title":"Incident Asthma, Asthma Exacerbations, and Asthma-Related Hospitalizations in Patients With Atopic Dermatitis","volume":"12","author":"Wan","year":"2024","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"8804","DOI":"10.1038\/ncomms9804","article-title":"Meta-analysis identifies seven susceptibility loci involved in the atopic march","volume":"6","author":"Marenholz","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jaad.2024.05.029","article-title":"Reduced atopic march risk in pediatric atopic dermatitis patients prescribed dupilumab versus conventional immunomodulatory therapy: A population-based cohort study","volume":"91","author":"Lin","year":"2024","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/cea.13156","article-title":"New insights into the phenotypes of atopic dermatitis linked with allergies and asthma in children: An overview","volume":"48","author":"Amat","year":"2018","journal-title":"Clin. Exp. Allergy J. Br. Soc. Allergy Clin. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1398-9995.2004.00652.x","article-title":"Environmental prevention in atopic eczema dermatitis syndrome (AEDS) and asthma: Avoidance of indoor allergens","volume":"59","author":"Capristo","year":"2004","journal-title":"Allergy"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.anai.2015.10.027","article-title":"Overlap of atopic, eosinophilic, and TH2-high asthma phenotypes in a general population with current asthma","volume":"116","author":"Tran","year":"2016","journal-title":"Ann. Allergy Asthma Immunol. Off. Publ. Am. Coll. Allergy Asthma Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jaad.2021.07.064","article-title":"Phenotypes of atopic dermatitis and the risk for subsequent asthma: A systematic review and meta-analysis","volume":"86","author":"Li","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1056\/NEJMc1700366","article-title":"Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis","volume":"376","author":"Mennini","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Saeki, H., Usami, M., Suzuki, K., Mochizuki, M., and Arima, K. (2025). Real-world safety and effectiveness of dupilumab for the treatment of atopic dermatitis: Two-year post-marketing surveillance in Japan. J. Cutan. Immunol. Allergy, 8.","DOI":"10.3389\/jcia.2025.14794"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1056\/NEJMoa2106567","article-title":"Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma","volume":"385","author":"Bacharier","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S2213-2600(24)00362-X","article-title":"Effect of dupilumab on exhaled nitric oxide, mucus plugs, and functional respiratory imaging in patients with type 2 asthma (VESTIGE): A randomised, double-blind, placebo-controlled, phase 4 trial","volume":"13","author":"Castro","year":"2025","journal-title":"Lancet Respir. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.anai.2019.02.009","article-title":"African American ancestry contribution to asthma and atopic dermatitis","volume":"122","author":"Daya","year":"2019","journal-title":"Ann. Allergy Asthma Immunol. Off. Publ. Am. Coll. Allergy Asthma Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"104296","DOI":"10.1016\/j.phrs.2019.104296","article-title":"Current and future targeted therapies for severe asthma: Managing treatment with biologics based on phenotypes and biomarkers","volume":"146","author":"Santus","year":"2019","journal-title":"Pharmacol. Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.anai.2009.10.002","article-title":"From atopic dermatitis to asthma: The atopic march","volume":"105","author":"Spergel","year":"2010","journal-title":"Ann. Allergy Asthma Immunol. Off. Publ. Am. Coll. Allergy Asthma Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/thorax.57.11.951","article-title":"Comparative epidemiology of atopic and non-atopic wheeze and diagnosed asthma in a national sample of English adults","volume":"57","author":"Court","year":"2002","journal-title":"Thorax"},{"key":"ref_53","first-page":"1s35","article-title":"Atopic dermatitis: Definition, epidemiology, natural history, severity and scores","volume":"132","year":"2005","journal-title":"Ann. Dermatol. Venereol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jaci.2018.11.006","article-title":"The atopic march and atopic multimorbidity: Many trajectories, many pathways","volume":"143","author":"Paller","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1002\/alr.21609","article-title":"Asthma: Definitions and pathophysiology","volume":"5","author":"Mims","year":"2015","journal-title":"Int. Forum Allergy Rhinol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1067\/mai.2003.30","article-title":"Asthma control in the Asia-Pacific region: The Asthma Insights and Reality in Asia-Pacific Study","volume":"111","author":"Lai","year":"2003","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/thoraxjnl-2017-210714","article-title":"Persistent variations in national asthma mortality, hospital admissions and prevalence by socioeconomic status and region in England","volume":"73","author":"Gupta","year":"2018","journal-title":"Thorax"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.jaad.2019.10.039","article-title":"The proteomic skin profile of moderate-to-severe atopic dermatitis patients shows an inflammatory signature","volume":"82","author":"Pavel","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.anai.2023.11.009","article-title":"Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology\/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- and Institute of Medicine-based recommendations","volume":"132","author":"Chu","year":"2024","journal-title":"Ann. Allergy Asthma Immunol. Off. Publ. Am. Coll. Allergy Asthma Immunol."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Bi, J., Bi, J., Ni, X., Lu, L., Yin, T., Mao, S., Zhang, R., and He, J. (2025). Bidirectional causal association and shared anti-inflammatory target of asthma and atopic dermatitis: A Mendelian randomization and colocalisation study. BMC Pulm. Med., 26.","DOI":"10.1186\/s12890-025-04042-9"}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/19\/8\/1149\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T10:46:42Z","timestamp":1784890002000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/19\/8\/1149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":60,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["ph19081149"],"URL":"https:\/\/doi.org\/10.3390\/ph19081149","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]}}}